Skip to main content
Caplight Logo









Therapex

Therapex

Private
SeoulHealthcare & Life Scienceshttps://therapexbio.com/

Total Funding Raised

$8.73M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Therapex is a biotechnology company that develops small molecule-based anti-cancer drugs and precision medicines for patients with drug-resistant tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

targeted oncologydrug discoverytyrosine kinase inhibitorTKItargeted protein degradationPROTACnon-small cell lung cancerNSCLCbiotechmolecular modelingin-silico drug designdegrader antibody conjugateDACblood-brain barrierdrug resistancebiopharmaprecision medicinetechnology licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Therapex Comparables

Compare Therapex with similar companies based on industry and business-model similarity.

Therapex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
J INTS BIO
94%
Black Diamond Therapeutics
78%
ArriVent
76%

Therapex Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 84% MoM, reaching 1.6K.

  • Jan 20, 2026

    Monthly visitors increased 201% MoM, reaching 4.1K.

Therapex Filings

Explore SEC and related filing metadata, where available.

Therapex filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Therapex's valuation, stock price, and market status.

Is Therapex a public or private company?

Therapex is a private company.

What is the current stock price of Therapex?

Therapex is a private company with no public stock price. No recent secondary market data is available.

How much is Therapex worth (valuation)?

Valuation information for Therapex is not publicly available.

Can I buy Therapex stock?

Therapex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Therapex's last funding round?

Funding round information for Therapex is not publicly available.

Who are the main investors in Therapex?

Investor information for Therapex is not publicly disclosed.

Will Therapex IPO soon?

No public IPO plans have been announced for Therapex.

How can I track Therapex secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Therapex's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range4
Year Founded2020
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?